Fonar Net Profit Margin 2010-2024 | FONR
Fonar net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Fonar Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-03-31 | $0.10B | $0.01B | 10.68% |
| 2023-12-31 | $0.10B | $0.01B | 12.75% |
| 2023-09-30 | $0.10B | $0.01B | 10.89% |
| 2023-06-30 | $0.10B | $0.01B | 9.18% |
| 2023-03-31 | $0.10B | $0.01B | 10.31% |
| 2022-12-31 | $0.10B | $0.01B | 8.25% |
| 2022-09-30 | $0.10B | $0.01B | 10.31% |
| 2022-06-30 | $0.10B | $0.01B | 12.24% |
| 2022-03-31 | $0.10B | $0.01B | 11.22% |
| 2021-12-31 | $0.10B | $0.01B | 13.54% |
| 2021-09-30 | $0.09B | $0.01B | 12.90% |
| 2021-06-30 | $0.09B | $0.01B | 11.11% |
| 2021-03-31 | $0.09B | $0.01B | 11.63% |
| 2020-12-31 | $0.09B | $0.01B | 8.24% |
| 2020-09-30 | $0.09B | $0.01B | 8.24% |
| 2020-06-30 | $0.09B | $0.01B | 9.30% |
| 2020-03-31 | $0.09B | $0.01B | 12.64% |
| 2019-12-31 | $0.09B | $0.01B | 15.91% |
| 2019-09-30 | $0.09B | $0.01B | 15.91% |
| 2019-06-30 | $0.09B | $0.01B | 16.09% |
| 2019-03-31 | $0.09B | $0.02B | 22.09% |
| 2018-12-31 | $0.08B | $0.02B | 21.43% |
| 2018-09-30 | $0.08B | $0.02B | 22.89% |
| 2018-06-30 | $0.08B | $0.02B | 23.46% |
| 2018-03-31 | $0.08B | $0.02B | 19.75% |
| 2017-12-31 | $0.08B | $0.02B | 23.75% |
| 2017-09-30 | $0.08B | $0.02B | 24.36% |
| 2017-06-30 | $0.08B | $0.02B | 24.36% |
| 2017-03-31 | $0.08B | $0.02B | 25.00% |
| 2016-12-31 | $0.08B | $0.02B | 21.33% |
| 2016-09-30 | $0.08B | $0.02B | 20.00% |
| 2016-06-30 | $0.07B | $0.02B | 20.27% |
| 2016-03-31 | $0.07B | $0.01B | 19.44% |
| 2015-12-31 | $0.07B | $0.01B | 18.57% |
| 2015-09-30 | $0.07B | $0.01B | 17.39% |
| 2015-06-30 | $0.07B | $0.01B | 15.94% |
| 2015-03-31 | $0.07B | $0.01B | 14.49% |
| 2014-12-31 | $0.07B | $0.01B | 14.49% |
| 2014-09-30 | $0.07B | $0.01B | 14.29% |
| 2014-06-30 | $0.07B | $0.01B | 14.49% |
| 2014-03-31 | $0.07B | $0.01B | 14.29% |
| 2013-12-31 | $0.07B | $0.01B | 13.85% |
| 2013-09-30 | $0.06B | $0.01B | 14.04% |
| 2013-06-30 | $0.05B | $0.01B | 14.00% |
| 2013-03-31 | $0.04B | $0.00B | 9.30% |
| 2012-12-31 | $0.04B | $0.00B | 9.76% |
| 2012-09-30 | $0.04B | $0.00B | 10.00% |
| 2012-06-30 | $0.04B | $0.00B | 10.00% |
| 2012-03-31 | $0.04B | $0.00B | 8.11% |
| 2011-12-31 | $0.04B | $0.00B | 8.33% |
| 2011-09-30 | $0.04B | $0.00B | 8.57% |
| 2011-06-30 | $0.03B | $0.00B | 5.88% |
| 2011-03-31 | $0.04B | $0.00B | 5.71% |
| 2010-12-31 | $0.03B | $0.00B | 2.94% |
| 2010-09-30 | $0.03B | $-0.00B | -2.94% |
| 2010-06-30 | $0.03B | $-0.00B | -9.38% |
| 2010-03-31 | $0.03B | $-0.00B | -9.09% |
| 2009-12-31 | $0.04B | $-0.00B | -5.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.096B | $0.099B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $181.079B | 23.71 |
| Stryker (SYK) | United States | $127.496B | 30.54 |
| Medtronic (MDT) | Ireland | $114.087B | 16.15 |
| Boston Scientific (BSX) | United States | $109.519B | 34.88 |
| EssilorLuxottica (ESLOY) | France | $102.905B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.259B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.858B | 28.37 |
| ResMed (RMD) | United States | $32.109B | 30.15 |
| Koninklijke Philips (PHG) | Netherlands | $25.984B | 20.13 |
| Terumo (TRUMY) | Japan | $25.953B | 36.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.724B | 15.79 |
| Baxter (BAX) | United States | $17.963B | 12.77 |
| Insulet (PODD) | United States | $13.116B | 58.16 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.406B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.382B | 27.41 |
| BellRing Brands (BRBR) | United States | $7.488B | 35.22 |
| Lantheus Holdings (LNTH) | United States | $5.522B | 13.76 |
| Haemonetics (HAE) | United States | $4.862B | 24.05 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.066B | 12.33 |
| Prestige Consumer Healthcare (PBH) | United States | $3.227B | 15.36 |
| Envista Holdings (NVST) | United States | $3.185B | 13.14 |
| Neogen (NEOG) | United States | $2.933B | 28.21 |
| QuidelOrtho (QDEL) | United States | $2.868B | 15.92 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.846B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.735B | 54.17 |
| TG Therapeutics (TGTX) | United States | $2.547B | 71.65 |
| ICU Medical (ICUI) | United States | $2.534B | 22.36 |
| Agios Pharmaceuticals (AGIO) | United States | $1.950B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.790B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.761B | 51.61 |
| Warby Parker (WRBY) | United States | $1.639B | 0.00 |
| InMode (INMD) | Israel | $1.550B | 8.24 |
| Owens & Minor (OMI) | United States | $1.424B | 12.41 |
| AdaptHealth (AHCO) | United States | $1.329B | 9.88 |
| National Vision Holdings (EYE) | United States | $1.240B | 39.45 |
| AtriCure (ATRC) | United States | $1.101B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.913B | 0.00 |
| Evolus (EOLS) | United States | $0.851B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.745B | 15.86 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| Valneva SE (VALN) | France | $0.618B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
| PetIQ (PETQ) | United States | $0.588B | 19.20 |
| TerrAscend (TSNDF) | Canada | $0.519B | 0.00 |
| Surmodics (SRDX) | United States | $0.494B | 30.91 |
| Jin Medical (ZJYL) | China | $0.465B | 0.00 |
| ZimVie (ZIMV) | United States | $0.464B | 39.58 |
| Aurora Cannabis (ACB) | Canada | $0.403B | 0.00 |
| Cerus (CERS) | United States | $0.364B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.364B | 11.71 |
| Biote (BTMD) | United States | $0.357B | 8.21 |
| Zynex (ZYXI) | United States | $0.346B | 47.30 |
| Viemed Healthcare (VMD) | United States | $0.276B | 27.35 |
| MacroGenics (MGNX) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.264B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.263B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.49 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.209B | 0.00 |
| Omeros (OMER) | United States | $0.200B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.197B | 0.00 |
| Veru (VERU) | United States | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.175B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.171B | 82.00 |
| InterCure (INCR) | Israel | $0.150B | 25.31 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.134B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 18.14 |
| Cellectar Biosciences (CLRB) | United States | $0.118B | 0.00 |
| MariMed (MRMD) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.089B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.085B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
| Safety Shot (SHOT) | United States | $0.072B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.054B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| Bright Green (BGXX) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.45 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.025B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |